Histamine releasing factor (HRF) in pannus of joints affected by rheumatoid arthritis. 2008

D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
Department of Experimental and Clinical Neuropathology, Medical Research Centre, Polish Academy of Sciences, 5 PawiƄskiego Str, 02-106 Warsaw, Poland. maslinskad@cmdik.pan.pl

UI MeSH Term Description Entries
D007719 Knee Joint A synovial hinge connection formed between the bones of the FEMUR; TIBIA; and PATELLA. Superior Tibiofibular Joint,Joint, Knee,Joint, Superior Tibiofibular,Knee Joints,Superior Tibiofibular Joints,Tibiofibular Joint, Superior
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000090324 Tumor Protein, Translationally-Controlled 1 A highly expressed protein in tumor cells, encoded by Tpt1 gene. It's involved in various cellular activities including protein synthesis, calcium-binding, MICROTUBULE stabilization, growth, and cell survival. Also, Tpt1 identified as a direct target gene of P53 tumor suppression. Histamine Releasing Factor,Histamine Releasing Factor, Lymphocyte-Dependent,Histamine-Releasing Factor (IgE-Dependent),Protein P23, Ehrlich Ascites Tumor,TPT1 Protein,Translationally-Controlled Tumor Protein,Factor, Histamine Releasing,Histamine Releasing Factor, Lymphocyte Dependent,Protein, TPT1,Protein, Translationally-Controlled Tumor,Translationally Controlled Tumor Protein,Tumor Protein, Translationally Controlled 1,Tumor Protein, Translationally-Controlled
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D001172 Arthritis, Rheumatoid A chronic systemic disease, primarily of the joints, marked by inflammatory changes in the synovial membranes and articular structures, widespread fibrinoid degeneration of the collagen fibers in mesenchymal tissues, and by atrophy and rarefaction of bony structures. Etiology is unknown, but autoimmune mechanisms have been implicated. Rheumatoid Arthritis
D014408 Biomarkers, Tumor Molecular products metabolized and secreted by neoplastic tissue and characterized biochemically in cells or BODY FLUIDS. They are indicators of tumor stage and grade as well as useful for monitoring responses to treatment and predicting recurrence. Many chemical groups are represented including HORMONES; ANTIGENS; amino and NUCLEIC ACIDS; ENZYMES; POLYAMINES; and specific CELL MEMBRANE PROTEINS and LIPIDS. Biochemical Tumor Marker,Cancer Biomarker,Carcinogen Markers,Markers, Tumor,Metabolite Markers, Neoplasm,Tumor Biomarker,Tumor Marker,Tumor Markers, Biochemical,Tumor Markers, Biological,Biochemical Tumor Markers,Biological Tumor Marker,Biological Tumor Markers,Biomarkers, Cancer,Marker, Biochemical Tumor,Marker, Biologic Tumor,Marker, Biological Tumor,Marker, Neoplasm Metabolite,Marker, Tumor Metabolite,Markers, Biochemical Tumor,Markers, Biological Tumor,Markers, Neoplasm Metabolite,Markers, Tumor Metabolite,Metabolite Markers, Tumor,Neoplasm Metabolite Markers,Tumor Markers, Biologic,Tumor Metabolite Marker,Biologic Tumor Marker,Biologic Tumor Markers,Biomarker, Cancer,Biomarker, Tumor,Cancer Biomarkers,Marker, Tumor,Markers, Biologic Tumor,Markers, Carcinogen,Metabolite Marker, Neoplasm,Metabolite Marker, Tumor,Neoplasm Metabolite Marker,Tumor Biomarkers,Tumor Marker, Biochemical,Tumor Marker, Biologic,Tumor Marker, Biological,Tumor Markers,Tumor Metabolite Markers

Related Publications

D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
December 1990, The Journal of allergy and clinical immunology,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
September 2023, Hand (New York, N.Y.),
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
April 1986, Agents and actions,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
June 2010, PloS one,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
May 1989, The Journal of rheumatology,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
July 1984, Annals of allergy,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
January 1986, Clinical and experimental immunology,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
January 2018, Molecular immunology,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
July 2016, The Journal of experimental medicine,
D Maslinska, and J Opertowska, and W Chabros, and M Maslinska, and A Grzybowska-Kowalczyk, and A Paradowska, and D Szukiewicz, and S Maslinski, and E Wojtecka-Lukasik
November 1989, Acta medica portuguesa,
Copied contents to your clipboard!